International Hepatology Archives - Page 10 of 47

ESMO China Voice: Personalized ctDNA Methylation for Monitoring MRD Post-Liver Cancer Resection by Fan Jia, Jian Zhou & Xinrong Yang’s Team

By Lisa Cui 2024.10.28

Amidst the serene morning mist gracing the wutong trees and frost enhancing the ripeness of oranges, the 2024 Annual Meeting of the European Society for Medical Oncology (ESMO) unfolds in…

Advancing Liver Cancer Treatment: Insights from Professor Tim Meyer

By Peng Longmei 2024.10.23

In a recent discussion, Professor Tim Meyer highlighted the importance of multidisciplinary care in liver cancer treatment. As systemic therapies evolve, including combinations of tyrosine kinase inhibitors and immunotherapy, there’s…

Metabolic-Related Diseases in Autoimmune Hepatitis Patients Promote Liver Fibrosis

By Peter W. PENG 2024.10.21

Introduction: Autoimmune hepatitis (AIH) is a chronic liver disease that affects both men and women, with about 30% of AIH cases occurring in individuals over 60 years old. Metabolic syndrome,…

Mesenchymal Stem Cell-Derived Exosomes Alleviate Liver Fibrosis

By Mourabit Halima 2024.10.20

Despite increasing knowledge of the cellular and molecular mechanisms underlying liver fibrosis, no Western medicine has been approved to treat the condition. Mesenchymal stem cells (MSCs), which are multipotent progenitor…

Hepatology | Association Between Metabolic-Associated Fatty Liver Disease and Subclinical Hypothyroidism in Adolescents

By Lisa Cui 2024.10.17

Editor's Note: A recent study led by Dr. Vidhu V. Thaker from Columbia University Medical Center has revealed a significant association between subclinical hypothyroidism and metabolic-associated steatotic liver disease (MASLD)…

2024 Nobel Prize | MicroRNAs (miRNAs) and Liver Diseases

By Mourabit Halima 2024.10.16

On October 7, 2024, the Nobel Prize in Physiology or Medicine was awarded to American scientist Victor Ambros and American biologist Gary Ruvkun. They were recognized for their discovery of…

Dr. Lai Wei: Interpretation of Key Points from the 2024 Edition of the Chinese Guidelines for the Prevention and Treatment of Metabolic (Non-Alcoholic

By Lisa Cui 2024.10.15

Editor's note: Liver diseases, primarily viral hepatitis, metabolic-associated fatty liver disease (MAFLD), and alcoholic liver disease, affect approximately 400 million people in China. With the increasing pace of life, unhealthy…

International Hepatology